Rentschler Biopharma, a Germany-based biopharmaceuticals manufacturer with a facility in Milford, is set to produce a novel ...

VarmX and Rentschler Biopharma expand collaboration from early development to late ‑ stage and commercial manufacturing of VMX-C001 VMX ‑ C001 ...

Contract development and manufacturing organization (CDMO) Rentschler Biopharma has announced a partnership with ...

The syndrome of disseminated intravascular coagulation (DIC) is a serious hypercoagulation state that occurs in a variety of disease states, including cancer. Although DIC is often associated with ...

CORRECTION of abnormally low concentration of plasma components is usually attempted by replacement therapy. However, evidence from studies of purpura fulminans in man 1,2 and from studies of the ...

The indications, pharmacokinetics, and therapeutic guidelines for available coagulation products are reviewed. Patients with hemophilia, von Wille-brand's disease (VWD), or acquired inhibitors to ...

In clinical laboratory settings, coagulation factor tests are routinely conducted to identify inherited or acquired deficiencies in patients suspected of an ongoing bleeding risk. These tests ...

For India, the future is likely a hybrid ecosystem: robust central laboratory analyzers complemented by decentralised, rapid-response coagulation devices. Sysmex is well positioned to operate across ...

The compendium of newly emerging and currently available hemophilia and anticoagulant treatments, while offering new choices for improved patient care, can create significant levels of interference ...

In a recent study published in the Trends in Endocrinology & Metabolism Journal, researchers explored the pathophysiological variables and coagulation abnormalities associated with long coronavirus ...